J.J. Garcia

Mayo Clinic in Arizona

Papers

1

Total Citations

53

H-Index

1

About

Dr. J.J. Garcia is a leading clinical researcher in head and neck oncology, with a primary focus on human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma. Their most cited work, the landmark MC1675 trial (53 citations), investigates de-escalated adjuvant radiation therapy (DART) as a strategy to reduce treatment toxicity while maintaining excellent outcomes for HPV-positive patients. This contribution addresses a critical unmet need: balancing curative intent with quality of life, as standard therapies often cause severe long-term side effects. By demonstrating that de-escalation is safe and effective, Garcia’s research has directly influenced clinical guidelines and sparked further trials worldwide. Their work is pivotal for young oncologists and researchers seeking to personalize cancer care, reduce overtreatment, and improve survivorship. With a growing citation impact, Dr. Garcia is recognized as a key voice in the paradigm shift toward less aggressive, yet equally curative, treatments for HPV-driven cancers—a model that may extend to other tumor types. Their dedication to evidence-based de-escalation continues to shape the future of radiation oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
53
Total Citations
53
Avg Citations/Paper
🏆 Most Cited Paper
MC1675, a Phase III Evaluation of De-Escalated Adjuvant Radiation Therapy (DART) vs. Standard Adjuvant Treatment for Human Papillomavirus Associated Oropharyngeal Squamous Cell Carcinoma
53 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: Mayo Clinic in Arizona

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago